Pfizer-BioNTech Boosters Now Available for 16+

On Dec. 9, the U.S. Food and Drug Administration (FDA) expanded eligibility for the Pfizer-BioNTech COVID-19 booster dose to individuals 16 and 17 years of age. The Centers of Disease Control and Prevention (CDC) followed suit, recommending everyone aged 16 and older receive a booster shot.

Adolescents 16 and 17 years old who received a Pfizer-BioNTech COVID-19 vaccine are eligible for a booster shot at least six months after completion of their primary series.

This expansion only applies to the Pfizer-BioNTech COVID vaccine and not the Moderna or Johnson & Johnson vaccines. The mix and match of doses (e.g., receiving a Moderna primary series and a Pfizer-BioNTech booster) is not currently permitted for this age group.

First and second doses and booster shots are available from UTMB by appointment. Schedule your COVID vaccine online.

Additional information on the Emergency Use Authorization for the Pfizer-BioNTech vaccine is available online:

With the emergence of the Omicron variant, getting a timely booster dose is more important than ever. Thank you for your ongoing efforts to curb the spread of disease this holiday season.